U.S. STOCKS ON THE MOVE-PepsiCo, Pearson, Ally Financial
U.S. STOCKS ON THE MOVE-GameStop Corp, GE Vernova, Daktronics
Heartbeam rises after FDA clears its cable‑free ECG software
Brief: Heartbeam Provides Update On Regulatory Path Following FDA Decision On 12-Lead ECG Synthesis Software Application
Brief: Heartbeam Says Received NSE Letter From FDA For 12-Lead ECG Synthesis Software - SEC Filing
NASDAQ RESUMED AT 10:37 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:32 AM
Heart monitor maker HeartBeam Q3 net loss widens on increased R&D expenses
Heartbeam Inc reports results for the quarter ended June 30 - Earnings Summary
Heartbeam Inc expected to post a loss of 16 cents a share - Earnings Preview
Heartbeam Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: HeartBeam Q1 Basic EPS USD -0.18
Heartbeam Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Heartbeam Successfully Meets Clinical Endpoints In Pivotal Study For Its Groundbreaking 12-Lead ECG Synthesis Technology
Brief: HeartBeam And AccurKardia Announce Strategic Collaboration To Advance Cardiac Monitoring Innovation
Brief: HeartBeam Reports Fourth Quarter and Full Year 2024 Results
Heartbeam Inc reports results for the quarter ended December 31 - Earnings Summary
Heartbeam Inc expected to post a loss of 19 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Teradyne, Keysight Technologies, Ametek